Eric D. Whitman
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 40
- CAR-T cell therapy research 28
- Cancer Immunotherapy and Biomarkers 15
- Cutaneous Melanoma Detection and Management 10
- Immunology 18
- Immunotherapy and Immune Responses 14
- Co-authors
- René González (9 shared papers)John Nemunaitis (8 shared papers)John A. Glaspy (4 shared papers)Gregory A. Daniels (8 shared papers)Thomas Amatruda (6 shared papers)Neil Senzer (2 shared papers)Tony Reid (2 shared papers)Kevin J. Harrington (2 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Annals of Oncology (4 papers)Melanoma Research (3 papers)Annals of Surgical Oncology (3 papers)Future Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Eric D. Whitman
68 papers receiving 2.1k citations
Eric D. Whitman's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.0k
- Immunology 738
- Emergency Medical Services 140
- Genetics 520
- Internal Medicine 52
Countries citing papers authored by Eric D. Whitman
This map shows the geographic impact of Eric D. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Whitman more than expected).
Fields of papers citing papers by Eric D. Whitman
This network shows the impact of papers produced by Eric D. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Whitman. The network helps show where Eric D. Whitman may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric D. Whitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma Hit paper breakdown → | 2009 | 492 |
| 2 | 2008 | 214 | |
| 3 | 2020 | 185 | |
| 4 | 1996 | 149 | |
| 5 | 2015 | 111 | |
| 6 | 2010 | 79 | |
| 7 | 2016 | 74 | |
| 8 | 1987 | 70 | |
| 9 | 2002 | 63 | |
| 10 | 2007 | 61 | |
| 11 | 2015 | 57 | |
| 12 | 1996 | 52 | |
| 13 | 1995 | 50 | |
| 14 | 2010 | 39 | |
| 15 | 2017 | 33 | |
| 16 | 2020 | 31 | |
| 17 | 2019 | 30 | |
| 18 | 2014 | 28 | |
| 19 | 1995 | 28 | |
| 20 | 1994 | 27 |
About Eric D. Whitman
Eric D. Whitman is a scholar working on Oncology, Immunology, Molecular Biology, Biotechnology and Genetics, having authored 75 papers that have together received 2.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (28 papers), Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (14 papers), Cancer Research and Treatments (12 papers), Virus-based gene therapy research (11 papers), Cutaneous Melanoma Detection and Management (10 papers), Central Venous Catheters and Hemodialysis (7 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (738 citations), Emergency Medical Services (140 citations), Genetics (520 citations) and Internal Medicine (52 citations). Eric D. Whitman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include René González, John Nemunaitis, John A. Glaspy, Gregory A. Daniels, Thomas Amatruda, Neil Senzer, Tony Reid, Kevin J. Harrington, Howard L. Kaufman and Mary Quasebarth. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, Annals of Surgical Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.